Download PDF
Endo-Praxis 2016; 32(04): 150-153
DOI: 10.1055/s-0042-117122
Originalia
© Georg Thieme Verlag KG Stuttgart · New York

Helicobacter pylori: Unterschätzen wir den Keim?

W. Fischbach
Medizinische Klinik II und Klinik für Palliativmedizin, Klinikum Aschaffenburg
› Author Affiliations
Further Information

Publication History

Publication Date:
10 November 2016 (online)

Also available at
    Permissions and Reprints

Die vorliegende Arbeit gibt einen aktuellen Überblick über die Helicobacter-pylori-Infektion, ihre Diagnose und Therapie.

Schlüsselwörter

Helicobacter-pylori-Infektion - Ulkuskrankheit - Magenkarzinom - Eradikationstherapie
 

  • Literatur

  • 1 Sugano K, Tack J, Kuipers EJ et al. Kyoto global censensus report on Helicobacter pylori gastritis. Gut 2015; 64: 1353-1367
    CrossrefPubMedGoogle Scholar
  • 2 Leodolter A, Kulig M, Brasch H et al. A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther 2001; 15: 1949-1958
    CrossrefGoogle Scholar
  • 3 Ruskoné-Fourmestraux A, Fischbach W, Aleman BMP et al. EGILS consensus report. Gastric extranodal marginal zone B cell lymphoma of MALT. Gut 2011; 60: 747-758
    CrossrefGoogle Scholar
  • 4 Fischbach W, Goebeler-Kolve ME, Dragosics B et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication: experience from a large prospective series. GUT 2004; 53: 34-37
    CrossrefPubMedGoogle Scholar
  • 5 Zullo A, Hassan C, Cristofari F et al. Effects of Helicobacter pylori Eradication on Early Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Clin Gastroenterol Hepatol 2010; 8: 105-110
    CrossrefGoogle Scholar
  • 6 Fuccio L, Zagari RM, Eusebi LH et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?. Ann Intern Med 2009; 151: 121-128
    CrossrefGoogle Scholar
  • 7 Chen Y, Segers S, Blaser MJ. Association between Helicobacter pylori and mortality in the NHANES III study. Gut 2013; 62: 1262-1269
    CrossrefGoogle Scholar
  • 8 Fischbach W, Malfertheiner P, Lynen Jansen P et al. S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit. Z Gastroenterol 2016; 54: 327-363
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Malfertheiner P, Megraud F, O’Morain CA et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646-664
    CrossrefPubMedGoogle Scholar
  • 10 Li BZ, Threapleton DE, Wang JY et al. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ 2015; 351: h4052 DOI: 10.1136/bmj.h4052.
    Google Scholar
  • 11 Megraud F, Coenen S, Versporten A et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013; 62: 34-42
    CrossrefPubMedGoogle Scholar
  • 12 Selgrad M, Meile J, Borschein J et al. Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies. Eur J Gastroenterol Hepatol 2013; 25: 1257-1260
    CrossrefGoogle Scholar